The U.S. government has earmarked $2.1B in total funds to support the development and production of a potential COVID-19 vaccine from pharmaceutical…
The departments of Defense and Health and Human Services awarded contracts worth $2.05B combined to biopharmaceutical companies Novavax and Regeneron to accelerate the…
AstraZeneca and the Department of Health and Human Services have signed a potential $1.2B public-private partnership agreement to further develop a recombinant adenovirus vaccine…
Seven companies have been awarded contracts worth more than $1.4B combined by the Department of Health and Human Services to supply ventilators…
Eli Lilly and Co. (NYSE: LLY) has received a potential $375M contract from the departments of Defense and Health and…
The Trump administration has awarded Abbott Laboratories (NYSE: ABT) a potential $760M contract to provide 150M rapid COVID-19 diagnostics tests.
The departments of Health and Human Services and Defense have signed a potential $1.5B agreement with Moderna to produce 100M…
Johnson & Johnson (NYSE: JNJ) has received $1B in U.S. government funding for large-scale production of a potential COVID-19 vaccine…
The Department of Health and Human Services has awarded Gaithersburg, Md.-based biopharmaceutical company Emergent BioSolutions a $628M task order to…
Health Agencies, Biopharmaceutical Firms Form Partnership to Accelerate COVID-19 Vaccine Development
The National Institutes of Health and three other U.S. health agencies have teamed up with the Foundation for the NIH,…
